| Literature DB >> 33324169 |
Laura C Caudal1, Davide Gobbo1, Anja Scheller1, Frank Kirchhoff1.
Abstract
Astroglial networks constitute a non-neuronal communication system in the brain and are acknowledged modulators of synaptic plasticity. A sophisticated set of transmitter receptors in combination with distinct secretion mechanisms enables astrocytes to sense and modulate synaptic transmission. This integrative function evolved around intracellular Ca2+ signals, by and large considered as the main indicator of astrocyte activity. Regular brain physiology meticulously relies on the constant reciprocity of excitation and inhibition (E/I). Astrocytes are metabolically, physically, and functionally associated to the E/I convergence. Metabolically, astrocytes provide glutamine, the precursor of both major neurotransmitters governing E/I in the central nervous system (CNS): glutamate and γ-aminobutyric acid (GABA). Perisynaptic astroglial processes are structurally and functionally associated with the respective circuits throughout the CNS. Astonishingly, in astrocytes, glutamatergic as well as GABAergic inputs elicit similar rises in intracellular Ca2+ that in turn can trigger the release of glutamate and GABA as well. Paradoxically, as gliotransmitters, these two molecules can thus strengthen, weaken or even reverse the input signal. Therefore, the net impact on neuronal network function is often convoluted and cannot be simply predicted by the nature of the stimulus itself. In this review, we highlight the ambiguity of astrocytes on discriminating and affecting synaptic activity in physiological and pathological state. Indeed, aberrant astroglial Ca2+ signaling is a key aspect of pathological conditions exhibiting compromised network excitability, such as epilepsy. Here, we gather recent evidence on the complexity of astroglial Ca2+ signals in health and disease, challenging the traditional, neuro-centric concept of segregating E/I, in favor of a non-binary, mutually dependent perspective on glutamatergic and GABAergic transmission.Entities:
Keywords: Ca2+; astrocyte; epilepsy; gliotransmission; glutamate; network plasticity; γ-aminobutyric acid
Year: 2020 PMID: 33324169 PMCID: PMC7726216 DOI: 10.3389/fncel.2020.609947
Source DB: PubMed Journal: Front Cell Neurosci ISSN: 1662-5102 Impact factor: 5.505
FIGURE 1Ca2+ signaling at the core of astroglial black box operations. (A) Astroglial receptome coordinates glutamate and GABA-induced intracellular Ca2+ signaling and subsequent gliotransmitter release. (B) Glutamate and GABA elicit Ca2+-dependent gliotransmitter-mediated congruent and incongruent modulation of network plasticity. Congruent signaling refers to contexts in which GABA and glutamate as initial stimuli exert inhibitory or excitatory effects on the neuronal network, respectively. Vice versa, incongruent signaling designates scenarios in which GABA has an excitatory and glutamate an inhibitory final impact on the network. Both congruent and incongruent signaling may involve the same gliotransmitters (highlighted on the arrows). 2-AG, 2-arachidonoylglycerol; AC, adenylate cyclase; ADP/ATP, adenosine di/tri-phosphate; AEA, anandamide; Best1, bestrophin-1 channel; cAMP, cyclic AMP; cys, cysteine; D-ser, D-serine; EAAT, excitatory amino acid transporter; eCB, endocannabinoids; GABA, γ-aminobutyric acid; GABAAR/GABABR, GABA receptors; GAT, GABA transporter; glu, glutamate; HC, hemichannel; IP3, inositol triphosphate; IP3R, inositol triphosphate receptor; mGluR, metabotropic glutamate receptor; NCX, sodium-calcium exchanger; NMDAR, N-methyl-D-aspartate receptor; P2XR, purinergic transmitter-gated ion channels; PLC, phospholipase C; TRPA1, transient receptor potential A1; VGCC, voltage-gated calcium channel; VRAC, volume-regulated anion channel; XC, cysteine-glutamate antiporter; ΔV, membrane potential.
Summary of congruent and incongruent signaling pathways evoked by glutamate and GABA, according to brain region, released gliotransmitter, and principal neuronal targets.